U.S. Urges India To Impose Strict Laws Against Counterfeit Drugs
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - The Office of the United States Trade Representative has taken a strong stand against counterfeit drugs in India, placing the country on the USTR priority watch list and calling for better and effective systems to check counterfeit drugs
You may also be interested in...
Is Sobering Tone On India IP Laws An Early Signal Of Reconciliation By U.S.?
Some lawyers say views on India’s patent laws may be softening despite India winding up again on the U.S. Priority Watch List.
Intellectual Property Protection: Foreign Governments Get To Argue Their Case To USTR Before Publication Of "Watch Lists"
For the first time, the U.S. Trade Representative is giving foreign governments and others a chance to publicly testify before issuing its 2010 Special 301 report on countries it deems do not provide adequate protection of intellectual property rights
Intellectual Property Protection: Foreign Governments Get To Argue Their Case To USTR Before Publication Of "Watch Lists"
For the first time, the U.S. Trade Representative is giving foreign governments and others a chance to publicly testify before issuing its 2010 Special 301 report on countries it deems do not provide adequate protection of intellectual property rights